A review of the activity that has taken place during 2025 for the East of England region.
Healthcare professionals and other NBTC stakeholders may wish to note an update from Jehovah’s Witnesses regarding individual decisions on the acceptance and donation of major blood components.
Following the February 2026 update to NICE QS138 Statement 2 on tranexamic acid (TXA), the QS138 Quality Insights quality improvement tool has been updated to reflect the broadened eligibility criteria.
National Transfusion Practitioners Network